Fort Washington Investment Advisors Inc. OH trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 1.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 518,274 shares of the company’s stock after selling 10,070 shares during the quarter. HCA Healthcare accounts for about 0.9% of Fort Washington Investment Advisors Inc. OH’s portfolio, making the stock its 26th largest position. Fort Washington Investment Advisors Inc. OH’s holdings in HCA Healthcare were worth $155,560,000 at the end of the most recent quarter.
A number of other hedge funds also recently modified their holdings of the business. Legacy Investment Solutions LLC acquired a new position in shares of HCA Healthcare in the 3rd quarter worth approximately $39,000. Capital Performance Advisors LLP bought a new stake in HCA Healthcare during the third quarter valued at $41,000. Benjamin F. Edwards & Company Inc. bought a new position in shares of HCA Healthcare in the 2nd quarter worth about $33,000. Canoe Financial LP acquired a new stake in HCA Healthcare during the third quarter worth approximately $41,000. Finally, Northwest Investment Counselors LLC acquired a new position in HCA Healthcare in the third quarter valued at approximately $44,000. Institutional investors and hedge funds own 62.73% of the company’s stock.
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on HCA shares. Oppenheimer boosted their target price on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research report on Monday, October 28th. Morgan Stanley reduced their target price on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 17th. TD Cowen cut their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a report on Monday, October 28th. Barclays cut their target price on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a report on Friday, November 8th. Finally, Raymond James downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $385.27.
Insider Transactions at HCA Healthcare
In related news, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. The trade was a 29.76 % decrease in their position. The disclosure for this sale can be found here. 1.70% of the stock is owned by corporate insiders.
HCA Healthcare Stock Up 2.6 %
HCA stock opened at $318.47 on Wednesday. The stock has a market cap of $80.67 billion, a P/E ratio of 14.30, a P/E/G ratio of 1.06 and a beta of 1.64. The stock’s fifty day simple moving average is $315.74 and its two-hundred day simple moving average is $353.08. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a 1-year low of $278.68 and a 1-year high of $417.14.
HCA Healthcare Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, December 27th. Shareholders of record on Friday, December 13th were given a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.83%. The ex-dividend date of this dividend was Friday, December 13th. HCA Healthcare’s dividend payout ratio is currently 11.85%.
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Featured Articles
- Five stocks we like better than HCA Healthcare
- 3 Best Fintech Stocks for a Portfolio Boost
- SAP’s Strong Momentum: A Bullish Setup for Investors
- What is a Stock Market Index and How Do You Use Them?
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- What is the NASDAQ Stock Exchange?
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.